Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
Delivery via inhalers could dramatically expand clinical utility and commercial opportunity for RPL554 LONDON, Dec. 17, 2018 (GLOBE NEWSWIRE) — […]